The empty intravenous (iv) bags market has seen considerable growth due to a variety of factors.
• The empty intravenous (IV) bags market has grown rapidly. It will increase from $6.36 billion in 2024 to $7.2 billion in 2025, reflecting a CAGR of 13.3%.
This growth is driven by the higher prevalence of chronic diseases, greater demand for intravenous therapies, an aging population, improvements in healthcare infrastructure, and the expansion of hospital and clinical services.
The empty intravenous (iv) bags market is expected to maintain its strong growth trajectory in upcoming years.
• The empty intravenous (IV) bags market is expected to grow rapidly, reaching $11.75 billion by 2029 at a CAGR of 13.0%.
This growth is driven by the expanding home healthcare market, rising malnutrition rates, growing demand for personalized medicine, increased surgical procedures, and healthcare service expansion in emerging markets. Trends include smart IV bags, biodegradable materials, contamination prevention, advanced manufacturing techniques, and EHR integration.
The rising number of surgical procedures is expected to drive the growth of the empty intravenous (IV) bag market in the future. Surgical procedures are medical treatments that involve invasive techniques to address health issues. The number of surgeries is increasing due to advancements in medical technology, an aging population, the prevalence of chronic diseases, and improved access to healthcare. Empty intravenous bags are crucial in surgical settings, where they are used to administer fluids, medications, and blood products. For example, in February 2024, the National Healthcare Statistics reported that cataract surgeries were the most common surgical procedures in the US in 2022. This growth in surgeries is contributing to the rise of the empty intravenous (IV) bag market.
The empty intravenous (IV) bags market covered in this report is segmented –
1) By Product: Polyvinyl Chloride, Non-Polyvinyl Chloride
2) By Type: Single Chamber, Multi-Chamber
3) By Material: Polypropylene, Polyester Ether, Ethylene Vinyl Acetate (EVA), Other Materials
4) By Capacity: 50 ML - 100 ML, 100 ML - 250 ML, 250 ML - 500 ML, Above 500 ML
5) By Application: Hospital, Clinic, Other Applications
Subsegments:
1) By Polyvinyl Chloride (PVC): Flexible PVC IV Bags, Rigid PVC IV Bags
2) By Non-Polyvinyl Chloride (Non-PVC): Ethylene Vinyl Acetate (EVA) IV Bags, Other Non-PVC Materials
Companies in the empty intravenous (IV) bags market are advancing recycling efforts to reduce environmental impact and promote circular economy practices in healthcare. For example, in December 2023, Baxter International Inc., a US-based healthcare company, launched the first IV bag recycling pilot program in the United States in partnership with Northwestern Medicine. This program aims to address the environmental concerns associated with single-use plastic IV bags.
Major companies operating in the empty intravenous (IV) bags market are:
• Pfizer Inc.
• Fresenius Medical Care AG KGaA
• Becton Dickinson and Company
• Amcor LLC
• Baxter International Inc.
• Grifols S.A.
• Hospira Inc.
• Nipro Corporation
• B. Braun Medical Inc.
• ICU Medical Inc.
• RENOLIT Healthcare
• Kiefel GmbH
• Medisca Inc.
• Bioteque Corporation
• BAUSCH Advanced Technology Group
• Jorgensen Laboratories LLC
• Technoflex
• Sippex IV bags
• AdvaCare Pharma Limited
• Tacy Medical Inc.
• Polycine GmbH
• JW Life Science Corp
• Mitra Industries Private Limited
North America was the largest region in the empty intravenous (IV) bags market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the empty intravenous (IV) bags market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.